- Advertisement -
Kuala Lampur For 15 years, the Malaysian Paediatric Association and its partners have been fighting for the inclusion of the Pneumococcal Conjugate Vaccine (PCV) into the National Immunization Program (NIP).
We studied the burden of the disease, researched the serotypes at play in our community, examined the increasing resistance of the bacterium to our arsenal of antibiotics and demonstrated the cost effectiveness of the PCV.
It took a new government in 2019 to appreciate our endeavours, empathise with the loss of innocent lives, the disabilities inflicted by the pneumococcus and the need for bigger investment in the health of our children. They rolled out the PCV in our NIP in 2020.
COMMENT | Time for a Ministry of Public Health
A
-
COMMENT | For 15 years, the Malaysian Paediatric Association and its partners have been fighting for the inclusion of the pneumococcal conjugate vaccine (PCV) into the National Immunisation Programme (NIP).
We studied the burden of the disease, researched the serotypes at play in our community, examined the increasing resistance of the bacterium to our arsenal of antibiotics and demonstrated the cost-effectiveness of the PCV.
It took a new government in 2019 to appreciate our endeavours, empathise with the loss of innocent lives and the disabilities inflicted by the pneumococcus, as well as the need for bigger investment in the health of our children. They rolled out the PCV in our NIP in 2020.